Claire M Rickard Selected Research

Vascular Access Devices (Arterial Line)

11/2022	Unnecessary removal of vascular access devices due to suspected infection in Australian intensive care units.
3/2019	Skin complications associated with vascular access devices: A secondary analysis of 13 studies involving 10,859 devices.
1/2019	Evaluation of Skin Colonisation And Placement of vascular access device Exit sites (ESCAPE Study).
4/2017	Draft Genome Sequence of Roseomonas mucosa Strain AU37, Isolated from a Peripheral Intravenous Catheter.
9/2016	Infection risks associated with peripheral vascular catheters.
11/2015	Nursing and midwifery practice for maintenance of vascular access device patency. A cross-sectional survey.
1/2013	Reducing the risk of infection associated with vascular access devices through nanotechnology: a perspective.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claire M Rickard Research Topics

Disease

48	Sepsis (Septicemia) 11/2022 - 02/2007
36	Infections 11/2022 - 08/2004
24	Phlebitis 04/2022 - 09/2009
7	Neoplasms (Cancer) 11/2022 - 02/2016
7	Critical Illness (Critically Ill) 04/2022 - 06/2003
7	Pain (Aches) 04/2022 - 05/2015
6	Wounds and Injuries (Trauma) 01/2021 - 11/2011
5	Catheter-Related Infections 10/2017 - 11/2004
4	Thrombosis (Thrombus) 01/2022 - 01/2019
4	Inflammation (Inflammations) 01/2019 - 04/2013
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 01/2016
3	Flushing 01/2020 - 11/2015
3	Bacteremia 04/2017 - 08/2004
2	Hemorrhage 01/2020 - 01/2019
2	Hematoma 01/2019 - 10/2015
2	Thrombophlebitis 01/2019 - 01/2018
2	Delirium 10/2006 - 02/2005
1	Hypersensitivity (Allergy) 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2021
1	Hemolysis 01/2021
1	Bacteriuria 01/2021
1	Arteritis 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Contact Dermatitis (Eczema, Contact) 09/2019
1	Aneurysm (Aneurysms) 01/2019
1	Fistula 01/2019
1	Wound Infection (Wound Infections) 01/2019
1	Irritant Dermatitis 07/2018
1	Erythema 07/2018
1	Intestinal Failure 07/2017
1	Vascular System Injuries 07/2017
1	Gastroschisis 07/2017
1	Healthcare-Associated Pneumonia 01/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Pneumothorax 01/2017
1	Respiratory Insufficiency (Respiratory Failure) 01/2017
1	Septic Shock (Toxic Shock Syndrome) 01/2017
1	Seroma 10/2015
1	Surgical Wound 10/2015
1	Chronic Disease (Chronic Diseases) 09/2015
1	Hypoalbuminemia 08/2004
1	Hypothermia 08/2004
1	Hyperglycemia 08/2004

Drug/Important Bio-Agent (IBA)

4	Polyvinyl Chloride (PVC)IBA 04/2022 - 06/2015
4	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 01/2021 - 07/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 01/2013
3	Polyurethanes (Polyurethane)IBA 09/2019 - 11/2011
2	Heparin (Liquaemin)FDA LinkGeneric 11/2022 - 11/2015
2	Pharmaceutical PreparationsIBA 04/2022 - 11/2011
2	ChlorhexidineIBA 01/2022 - 01/2021
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2017
2	Local Anti-Infective Agents (Antiseptics)IBA 01/2021 - 12/2019
2	LipidsIBA 09/2013 - 08/2004
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2022
1	Levetiracetam (Keppra)FDA LinkGeneric 04/2022
1	Nitroglycerin (Dynamite)FDA LinkGeneric 04/2022
1	Nicardipine (Dagan)FDA LinkGeneric 04/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 04/2022
1	polihexanideIBA 01/2022
1	N 30IBA 03/2021
1	PotassiumIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	2-Propanol (Isopropyl Alcohol)FDA LinkGeneric 01/2021
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 02/2019
1	Floxacillin (Flucloxacillin)IBA 01/2018
1	Intravenous Fat EmulsionsIBA 01/2018
1	Tissue Adhesives (Tissue Adhesive)IBA 08/2017
1	Sodium Chloride FDA LinkGeneric 11/2015
1	N-acetyltryptophanamide (NATA)IBA 11/2015
1	Anti-Infective Agents (Microbicides)IBA 01/2013
1	Aligeron (AS 2)IBA 11/2011
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 02/2007

Therapy/Procedure

70	Catheters 11/2022 - 08/2004
13	Central Venous Catheters 01/2022 - 08/2004
10	Critical Care (Surgical Intensive Care) 01/2022 - 08/2004
10	Therapeutics 05/2021 - 08/2004
7	Vascular Access Devices (Arterial Line) 11/2022 - 01/2013
6	Length of Stay 01/2019 - 02/2005
5	Intravenous Administration 11/2019 - 08/2004
4	Cannula 01/2020 - 06/2003
3	Treatment Delay 03/2021 - 07/2017
3	Parenteral Nutrition 03/2018 - 07/2017
2	Device Removal (Removal, Device) 11/2022 - 05/2015
1	Urinary Catheters 01/2021
1	Infusion Pumps (Infusion Pump) 01/2021
1	Transjugular Intrahepatic Portasystemic Shunt 05/2020
1	Hand Hygiene 01/2019
1	Blood Transfusion (Blood Transfusions) 01/2019
1	Tourniquets 01/2019
1	Stents 01/2019
1	Sutures (Suture) 08/2017
1	Arthroplasty 10/2015
1	Negative-Pressure Wound Therapy 10/2015
1	Duration of Therapy 09/2012
1	Nutritional Support (Artificial Feeding) 11/2011
1	Injections 08/2004
1	Renal Replacement Therapy (Therapies, Renal Replacement) 08/2004
1	Total Parenteral Nutrition 08/2004